---
title: "Naltrexone - Alcoholism"
sidebar: mydoc_sidebar
permalink: db00704-mesh-d000437-1.html
toc: false 
---


Path ID: `DB00704_MESH_D000437_1`
{% include image.html url="images/db00704-mesh-d000437-1.png" file="db00704-mesh-d000437-1.png" alt="db00704-mesh-d000437-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009270 | Naltrexone | Drug |
| UniProt:P41145 | Kappa-type opioid receptor | Protein |
| UniProt:P01213 | Proenkephalin-B | Protein |
| HP:0030858 | Addictive behavior | PhenotypicFeature |
| UniProt:P41143 | Delta-type opioid receptor | Protein |
| UniProt:P35372 | Mu-type opioid receptor | Protein |
| GO:0061527 | Dopamine secretion, neurotransmission | BiologicalProcess |
| MESH:D000437 | Alcoholism | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Naltrexone | DECREASES ACTIVITY OF | Kappa-Type Opioid Receptor |
| Kappa-Type Opioid Receptor | MOLECULARLY INTERACTS WITH | Proenkephalin-B |
| Proenkephalin-B | POSITIVELY CORRELATED WITH | Addictive Behavior |
| Naltrexone | DECREASES ACTIVITY OF | Delta-Type Opioid Receptor |
| Delta-Type Opioid Receptor | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Naltrexone | DECREASES ACTIVITY OF | Mu-Type Opioid Receptor |
| Mu-Type Opioid Receptor | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | POSITIVELY CORRELATED WITH | Addictive Behavior |
| Addictive Behavior | OCCURS IN | Alcoholism |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00704](https://go.drugbank.com/drugs/DB00704)
  - [https://en.wikipedia.org/wiki/Naltrexone#Pharmacology](https://en.wikipedia.org/wiki/Naltrexone#Pharmacology)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565602/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565602/)
